Analyst Price Targets — LIVN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 25, 2026 8:54 pm | — | Stifel Nicolaus | $80.00 | $70.29 | TheFly | LivaNova price target raised to $80 from $70 at Stifel |
| February 25, 2026 5:09 pm | Mike Matson | Needham | $81.00 | $70.29 | StreetInsider | Livanova (LIVN) PT Raised to $81 at Needham |
| February 19, 2026 1:24 pm | Adam Maeder | Piper Sandler | $85.00 | $67.33 | StreetInsider | Piper Sandler on Livanova (LIVN): 'Favorite SMID Value Name On Our List' |
| January 9, 2026 12:21 pm | — | Barclays | $67.00 | $64.95 | TheFly | LivaNova price target raised to $67 from $58 at Barclays |
| January 9, 2026 10:50 am | David Roman | Goldman Sachs | $66.00 | $64.95 | TheFly | LivaNova price target raised to $66 from $56 at Goldman Sachs |
| December 19, 2025 1:01 am | Brett Fishbin | KeyBanc | $81.00 | $62.08 | TheFly | LivaNova initiated with an Overweight at KeyBanc |
| December 17, 2025 11:58 am | Anthony Petrone | Mizuho Securities | $72.00 | $63.08 | TheFly | LivaNova price target raised to $72 from $70 at Mizuho |
| December 16, 2025 10:38 am | — | Robert W. Baird | $75.00 | $63.05 | TheFly | LivaNova price target raised to $75 from $70 at Baird |
| October 1, 2025 9:14 am | — | Goldman Sachs | $55.00 | $52.38 | TheFly | LivaNova downgraded to Neutral from Buy at Goldman Sachs |
| March 7, 2025 10:16 am | — | Barclays | $56.00 | $39.17 | TheFly | LivaNova price target lowered to $56 from $58 at Barclays |
Latest News for LIVN
Aberdeen Group plc trimmed its position in shares of LivaNova PLC (NASDAQ: LIVN) by 89.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,850 shares of the company's stock after selling 220,443 shares during the quarter. Aberdeen Group plc's holdings in
SG Americas Securities LLC raised its stake in shares of LivaNova PLC (NASDAQ: LIVN) by 83.9% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 24,257 shares of the company's stock after buying an additional 11,066 shares during the quarter. SG Americas
Allspring Global Investments Holdings LLC lessened its holdings in shares of LivaNova PLC (NASDAQ: LIVN) by 8.9% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 201,832 shares of the company's stock after selling 19,629 shares during the period. Allspring Global Investments Holdings LLC
Exchange Traded Concepts LLC purchased a new position in shares of LivaNova PLC (NASDAQ: LIVN) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,768 shares of the company's stock, valued at approximately $970,000. A number of other
LIVN wins FDA nod for its aura6000 sleep apnea system, marking a pivotal step in neurostimulation with strong trial results and new growth potential.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LIVN.
U.S. House Trading
No House trades found for LIVN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.